Cargando…
3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome
BACKGROUND: Obesity is a growing epidemic with limited effective treatments and an important risk factor for several diseases such as metabolic syndrome (MetS). In this study, we aimed to investigate the effect of 3-amino-1,2,4-triazole (ATZ), an inhibitor of catalase and heme synthesis, in a murine...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174953/ https://www.ncbi.nlm.nih.gov/pubmed/32351670 http://dx.doi.org/10.1155/2020/3025361 |
_version_ | 1783524731576647680 |
---|---|
author | Nunes-Souza, Valéria Dias-Júnior, Nelson Miguel Eleutério-Silva, Marcos Antônio Ferreira-Neves, Vanessa P. Moura, Fabiana Andréa Alenina, Natalia Bader, Michael Rabelo, Luíza A. |
author_facet | Nunes-Souza, Valéria Dias-Júnior, Nelson Miguel Eleutério-Silva, Marcos Antônio Ferreira-Neves, Vanessa P. Moura, Fabiana Andréa Alenina, Natalia Bader, Michael Rabelo, Luíza A. |
author_sort | Nunes-Souza, Valéria |
collection | PubMed |
description | BACKGROUND: Obesity is a growing epidemic with limited effective treatments and an important risk factor for several diseases such as metabolic syndrome (MetS). In this study, we aimed to investigate the effect of 3-amino-1,2,4-triazole (ATZ), an inhibitor of catalase and heme synthesis, in a murine model for MetS. METHODS: Male C57BL/6 mice with high-fat diet-induced MetS received ATZ (500 mg·kg(−1)·24 h(−1)) for 12 weeks. RESULTS: The HFD group showed increased blood pressure and body weight, enhanced fat deposition accompanied by an increase in adipocyte diameter, and decreased lipolysis in white adipose tissue (WAT). The expression of genes related to inflammation was increased in WAT of the HFD group. Concurrently, these mice exhibited an increase in leptin, nonesterified fatty acid (NEFA), insulin, and glucose in plasma, coupled with glucose intolerance and insulin resistance. Strikingly, ATZ prevented the increase in blood pressure and the HFD-induced obesity as observed by lower body weight, WAT index, triglycerides, NEFA, and leptin in plasma. ATZ treatment also prevented the HFD-induced increase in adipocyte diameter and even induced marked atrophy and the accumulation of macrophages in this tissue. ATZ treatment also improved glucose metabolism by increasing glucose tolerance and insulin sensitivity, GLUT4 mRNA expression in WAT in parallel to decreased insulin levels. CONCLUSIONS: In the context of HFD-induced obesity and metabolic syndrome, the fat loss induced by ATZ is probably due to heme synthesis inhibition, which blocks adipogenesis by probably decreased RevErbα activity, leading to apoptosis of adipocytes and the recruitment of macrophages. As a consequence of fat loss, ATZ elicits a beneficial systemic antiobesity effect and improves the metabolic status. |
format | Online Article Text |
id | pubmed-7174953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-71749532020-04-29 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome Nunes-Souza, Valéria Dias-Júnior, Nelson Miguel Eleutério-Silva, Marcos Antônio Ferreira-Neves, Vanessa P. Moura, Fabiana Andréa Alenina, Natalia Bader, Michael Rabelo, Luíza A. Oxid Med Cell Longev Research Article BACKGROUND: Obesity is a growing epidemic with limited effective treatments and an important risk factor for several diseases such as metabolic syndrome (MetS). In this study, we aimed to investigate the effect of 3-amino-1,2,4-triazole (ATZ), an inhibitor of catalase and heme synthesis, in a murine model for MetS. METHODS: Male C57BL/6 mice with high-fat diet-induced MetS received ATZ (500 mg·kg(−1)·24 h(−1)) for 12 weeks. RESULTS: The HFD group showed increased blood pressure and body weight, enhanced fat deposition accompanied by an increase in adipocyte diameter, and decreased lipolysis in white adipose tissue (WAT). The expression of genes related to inflammation was increased in WAT of the HFD group. Concurrently, these mice exhibited an increase in leptin, nonesterified fatty acid (NEFA), insulin, and glucose in plasma, coupled with glucose intolerance and insulin resistance. Strikingly, ATZ prevented the increase in blood pressure and the HFD-induced obesity as observed by lower body weight, WAT index, triglycerides, NEFA, and leptin in plasma. ATZ treatment also prevented the HFD-induced increase in adipocyte diameter and even induced marked atrophy and the accumulation of macrophages in this tissue. ATZ treatment also improved glucose metabolism by increasing glucose tolerance and insulin sensitivity, GLUT4 mRNA expression in WAT in parallel to decreased insulin levels. CONCLUSIONS: In the context of HFD-induced obesity and metabolic syndrome, the fat loss induced by ATZ is probably due to heme synthesis inhibition, which blocks adipogenesis by probably decreased RevErbα activity, leading to apoptosis of adipocytes and the recruitment of macrophages. As a consequence of fat loss, ATZ elicits a beneficial systemic antiobesity effect and improves the metabolic status. Hindawi 2020-04-13 /pmc/articles/PMC7174953/ /pubmed/32351670 http://dx.doi.org/10.1155/2020/3025361 Text en Copyright © 2020 Valéria Nunes-Souza et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nunes-Souza, Valéria Dias-Júnior, Nelson Miguel Eleutério-Silva, Marcos Antônio Ferreira-Neves, Vanessa P. Moura, Fabiana Andréa Alenina, Natalia Bader, Michael Rabelo, Luíza A. 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title_full | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title_fullStr | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title_full_unstemmed | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title_short | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
title_sort | 3-amino-1,2,4-triazole induces quick and strong fat loss in mice with high fat-induced metabolic syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174953/ https://www.ncbi.nlm.nih.gov/pubmed/32351670 http://dx.doi.org/10.1155/2020/3025361 |
work_keys_str_mv | AT nunessouzavaleria 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT diasjuniornelsonmiguel 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT eleuteriosilvamarcosantonio 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT ferreiranevesvanessap 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT mourafabianaandrea 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT aleninanatalia 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT badermichael 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome AT rabeloluizaa 3amino124triazoleinducesquickandstrongfatlossinmicewithhighfatinducedmetabolicsyndrome |